ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 118 filers reported holding ANI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,050,886 | +116.2% | 18,100 | +100.5% | 0.00% | 0.0% |
| Q2 2023 | $485,977 | +52.3% | 9,028 | +12.4% | 0.00% | – |
| Q1 2023 | $319,110 | +35.6% | 8,034 | +37.3% | 0.00% | – |
| Q4 2022 | $235,386 | -99.9% | 5,851 | -22.1% | 0.00% | – |
| Q3 2022 | $241,307,000 | +42.8% | 7,508 | +31.9% | 0.00% | – |
| Q2 2022 | $168,941,000 | +3.7% | 5,694 | -1.8% | 0.00% | – |
| Q1 2022 | $162,982,000 | -48.9% | 5,798 | -16.2% | 0.00% | – |
| Q4 2021 | $318,966,000 | -3.9% | 6,922 | -31.6% | 0.00% | – |
| Q3 2021 | $332,007,000 | +101.6% | 10,116 | +115.3% | 0.00% | – |
| Q2 2021 | $164,700,000 | +30.8% | 4,699 | +34.9% | 0.00% | – |
| Q1 2021 | $125,876,000 | +74.6% | 3,483 | +40.3% | 0.00% | – |
| Q4 2020 | $72,077,000 | +5.0% | 2,482 | +2.0% | 0.00% | – |
| Q3 2020 | $68,663,000 | +296.9% | 2,434 | +355.0% | 0.00% | – |
| Q2 2020 | $17,302,000 | -88.4% | 535 | -85.4% | 0.00% | – |
| Q1 2020 | $149,027,000 | +17.0% | 3,658 | +77.1% | 0.00% | – |
| Q4 2019 | $127,349,000 | +32.0% | 2,065 | +56.0% | 0.00% | – |
| Q3 2019 | $96,493,000 | +31.2% | 1,324 | +47.9% | 0.00% | – |
| Q2 2019 | $73,569,000 | -37.4% | 895 | -46.3% | 0.00% | – |
| Q1 2019 | $117,590,000 | +87003.7% | 1,667 | +55466.7% | 0.00% | – |
| Q4 2018 | $135,000 | -99.1% | 3 | -98.9% | 0.00% | – |
| Q3 2018 | $15,605,000 | -15.4% | 276 | 0.0% | 0.00% | – |
| Q2 2018 | $18,437,000 | -88.0% | 276 | -89.6% | 0.00% | – |
| Q1 2018 | $154,050,000 | -31.2% | 2,646 | -23.8% | 0.00% | – |
| Q4 2017 | $223,770,000 | -4.0% | 3,472 | -21.9% | 0.00% | -100.0% |
| Q3 2017 | $233,213,000 | +131.6% | 4,443 | +106.5% | 0.00% | – |
| Q2 2017 | $100,714,000 | +36.7% | 2,152 | +44.6% | 0.00% | – |
| Q1 2017 | $73,671,000 | -9.8% | 1,488 | +10.4% | 0.00% | – |
| Q4 2016 | $81,716,000 | +13.2% | 1,348 | +23.9% | 0.00% | – |
| Q3 2016 | $72,189,000 | -45.3% | 1,088 | -54.0% | 0.00% | -100.0% |
| Q2 2016 | $131,958,000 | +223.2% | 2,364 | +94.9% | 0.00% | – |
| Q1 2016 | $40,830,000 | -38.3% | 1,213 | -17.3% | 0.00% | – |
| Q4 2015 | $66,146,000 | +4.5% | 1,466 | -8.5% | 0.00% | – |
| Q3 2015 | $63,295,000 | +55.7% | 1,602 | +144.6% | 0.00% | – |
| Q2 2015 | $40,643,000 | +313.9% | 655 | +317.2% | 0.00% | – |
| Q1 2015 | $9,820,000 | +207.3% | 157 | +38.9% | 0.00% | – |
| Q3 2014 | $3,196,000 | – | 113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |